Wedbush Securities’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$369K Buy
21,995
+700
+3% +$11.7K 0.01% 741
2025
Q1
$327K Sell
21,295
-2
-0% -$31 0.01% 767
2024
Q4
$469K Buy
21,297
+214
+1% +$4.71K 0.02% 635
2024
Q3
$380K Sell
21,083
-7,321
-26% -$132K 0.01% 712
2024
Q2
$462K Sell
28,404
-3,438
-11% -$55.9K 0.02% 661
2024
Q1
$449K Buy
31,842
+4,101
+15% +$57.8K 0.02% 685
2023
Q4
$290K Sell
27,741
-775
-3% -$8.1K 0.01% 788
2023
Q3
$291K Sell
28,516
-5,104
-15% -$52.1K 0.01% 744
2023
Q2
$253K Sell
33,620
-1,300
-4% -$9.78K 0.01% 832
2023
Q1
$309K Sell
34,920
-832
-2% -$7.36K 0.02% 743
2022
Q4
$326K Sell
35,752
-5,300
-13% -$48.3K 0.02% 699
2022
Q3
$331K Buy
41,052
+3,050
+8% +$24.6K 0.02% 678
2022
Q2
$286K Sell
38,002
-250
-0.7% -$1.88K 0.02% 764
2022
Q1
$359K Sell
38,252
-150
-0.4% -$1.41K 0.02% 727
2021
Q4
$308K Sell
38,402
-400
-1% -$3.21K 0.01% 860
2021
Q3
$378K Sell
38,802
-1,850
-5% -$18K 0.02% 743
2021
Q2
$402K Sell
40,652
-206
-0.5% -$2.04K 0.02% 714
2021
Q1
$471K Buy
40,858
+9,787
+31% +$113K 0.03% 599
2020
Q4
$300K Sell
31,071
-3,657
-11% -$35.3K 0.03% 649
2020
Q3
$313K Sell
34,728
-2,556
-7% -$23K 0.03% 601
2020
Q2
$460K Sell
37,284
-14,412
-28% -$178K 0.04% 452
2020
Q1
$464K Buy
51,696
+2,057
+4% +$18.5K 0.06% 385
2019
Q4
$486K Buy
49,639
+7,292
+17% +$71.4K 0.04% 488
2019
Q3
$291K Buy
42,347
+10,403
+33% +$71.5K 0.03% 651
2019
Q2
$295K Buy
31,944
+3,559
+13% +$32.9K 0.03% 636
2019
Q1
$445K Buy
28,385
+1,015
+4% +$15.9K 0.05% 446
2018
Q4
$422K Sell
27,370
-3,625
-12% -$55.9K 0.05% 412
2018
Q3
$668K Sell
30,995
-1,550
-5% -$33.4K 0.08% 298
2018
Q2
$791K Sell
32,545
-15,975
-33% -$388K 0.1% 236
2018
Q1
$829K Sell
48,520
-31,432
-39% -$537K 0.11% 224
2017
Q4
$1.52M Sell
79,952
-17,023
-18% -$323K 0.19% 122
2017
Q3
$1.71M Buy
96,975
+24,828
+34% +$437K 0.22% 92
2017
Q2
$2.4M Buy
72,147
+16,980
+31% +$564K 0.31% 66
2017
Q1
$1.77M Buy
55,167
+28,597
+108% +$918K 0.24% 83
2016
Q4
$963K Buy
26,570
+19,020
+252% +$689K 0.14% 168
2016
Q3
$347K Buy
7,550
+1,995
+36% +$91.7K 0.05% 454
2016
Q2
$279K Buy
5,555
+322
+6% +$16.2K 0.05% 487
2016
Q1
$280K Buy
5,233
+920
+21% +$49.2K 0.05% 458
2015
Q4
$283K Sell
4,313
-193
-4% -$12.7K 0.05% 432
2015
Q3
$254K Buy
4,506
+991
+28% +$55.9K 0.05% 442
2015
Q2
$208K Sell
3,515
-424
-11% -$25.1K 0.04% 562
2015
Q1
$245K Sell
3,939
-853
-18% -$53.1K 0.04% 504
2014
Q4
$276K Sell
4,792
-1,565
-25% -$90.1K 0.04% 434
2014
Q3
$342K Sell
6,357
-7,720
-55% -$415K 0.05% 357
2014
Q2
$738K Sell
14,077
-16
-0.1% -$839 0.12% 182
2014
Q1
$745K Sell
14,093
-4,053
-22% -$214K 0.13% 164
2013
Q4
$727K Sell
18,146
-324
-2% -$13K 0.17% 145
2013
Q3
$698K Sell
18,470
-62
-0.3% -$2.34K 0.18% 137
2013
Q2
$726K Buy
+18,532
New +$726K 0.2% 132